Reference Values for Gastric Emptying Scintigraphy After Bariatric Surgery
Launched by RIJNSTATE HOSPITAL · Apr 25, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 65 years;
- • RYGB or SG as primary bariatric surgery;
- • A 2 year post-operative period without significant peri-operative or postoperative complications that could affect oesophageal transit, GE, or weight loss;
- • "Normal" weight loss, according to our expectations (25% \< TWL \< 35%);
- • Participants must be able to adhere to the study visit schedule and protocol requirements;
- • Participants must be able to give informed consent (IC) prior to any study procedures;
- • Willing to be informed about incidental findings of pathology and approving of reporting this to their general physician.
- Exclusion Criteria:
- • Pre-existent oesophageal or gastric motility disorders, dysphagia, reflux, dumping syndrome, (postprandial) abdominal pain, neurological or metabolic conditions that significantly affect oesophageal or gastric motility;
- • When using proton pump inhibitors (PPI) or H2-antagonists, the inability to stop using them for 3 days;
- • Using opioids;
- • Previous oesophago-gastric surgery, other than bariatric surgery;
- • Unable to stop smoking for 24h;
- • Pregnancy or breast-feeding;
- • Patients with a drug or alcohol addiction;
- • Gluten intolerance;
- • Intolerance to tracer ingredients;
- • Participating in another scientific study at the same time, if this study interferes with the current study in any way.
About Rijnstate Hospital
Rijnstate Hospital is a leading healthcare institution based in the Netherlands, dedicated to providing high-quality patient care and advancing medical research. With a strong emphasis on innovation and collaboration, Rijnstate Hospital actively engages in clinical trials to explore new treatment options and improve patient outcomes across various medical fields. The hospital's multidisciplinary approach integrates the expertise of healthcare professionals, researchers, and academic partners, ensuring rigorous scientific methodologies and adherence to ethical standards. Committed to enhancing the health and well-being of the communities it serves, Rijnstate Hospital plays a pivotal role in the advancement of medical knowledge and the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Arnhem, Gelderland, Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported